Maridebart Cafraglutide (AMG 133)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Maridebart Cafraglutide (AMG 133), covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations [Phase 1]